| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 5.5e-05 | 1 |